BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4969752)

  • 1. [The clinical significance of some indicators of autoimmunity in typhoid patients].
    Timina VP
    Sov Med; 1968 Jan; 31(1):66-9. PubMed ID: 4969752
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of development of carriers in typhoid and paratyphoid fever.
    Kilesso VA; Bilibin AF; Tendetnik YY; Kornilova II; Antonova IV; Musabayev IK; Nevsky MV; Kusminova ML; Vasilyeva AV
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):95-103. PubMed ID: 4196796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiments on antibody formation following thymectomy in adult rabbits].
    Hempel HC; Grimm J; Schwarz ER; Hofmann K; Korn D
    Dtsch Gesundheitsw; 1969 Jul; 24(28):1304-7. PubMed ID: 4987620
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of autoimmune processes in the pathogenesis of leukopenia and thrombocytopenia in typhoid during immunotherapy].
    Timina VP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Oct; 44(10):99-102. PubMed ID: 4979155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Laboratory research concerning the effectiveness of a typhoid-paratyphoid A and B vaccine administered orally].
    Nestoresco N; Vlădoianu IR; Dimache G; Dimache V; Petruşca J; Bórs A; Constantinesco L
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):417-22. PubMed ID: 4961444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
    Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
    Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
    Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of specific cellular immunoreactivity in typhoid fever.
    Nyerges G; Ferencz A; Funk O
    Acta Microbiol Acad Sci Hung; 1979; 26(4):321-4. PubMed ID: 121028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the problem of the bacteria carrier state of typhoid and paratyphoid fevers].
    Ferdinand IaM; Lebedeva EA; Marisova AP; Romanova VP; Ol'shteĭn SE; Gabrilovich AB
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):90-4. PubMed ID: 4976154
    [No Abstract]   [Full Text] [Related]  

  • 10. [Considerations on the value of some laboratory tests for the evaluation of the effectiveness of the TAB vaccine].
    Chiresco N; Rímniceanu I
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):261-6. PubMed ID: 4961118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characterization of typhoid O and H agglutinins and paratyphoid A and B agglutinins in full-term newborn infants after stimulation with typhoid-paratyphoid vaccine].
    Turbessi G; Ungari S; Aiuti F; Serra GB; Ricci G
    Riv Ist Sieroter Ital; 1966; 41(4):255-63. PubMed ID: 4966014
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the body's response to the administration of chemically sorbed typhoid-paratyphoid vaccine].
    Dobrodeeva LK
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Aug; 43(8):143-4. PubMed ID: 4978576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Appearance of anti-gamma globulin factors after administration of vaccines].
    Masala C; Pala AM; De Philippis CV
    Folia Allergol (Roma); 1967; 14(6):602-6. PubMed ID: 4171232
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the problem of experimental evaluation of vaccines against typhoid and paratyphoid].
    MATEJOVSKA D; JELINEK J; RASKA K
    Cesk Epidemiol Mikrobiol Imunol; 1959 Sep; 8():299-303. PubMed ID: 14422227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Material on the characteristics of the active immunity test in the evaluation of the immunogenicity of typhoid-paratyphoid vaccines in experiments on white mice].
    Rumiantsev SN; Karpenkova NI; Chalenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):9-15. PubMed ID: 4623777
    [No Abstract]   [Full Text] [Related]  

  • 17. Agglutinins for typhoid and paratyphoid.
    MODI BG; VAIDYA AB
    Indian J Pathol Bacteriol; 1962 Jul; 5():124-30. PubMed ID: 14474958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Should typhoid-paratyphoid vaccination be obligatory?].
    THIBAULT P
    Concours Med; 1960 Dec; 82():6193-4. PubMed ID: 13776267
    [No Abstract]   [Full Text] [Related]  

  • 19. Size of the immunizing dose and postvaccination immunity to typhoid and paratyphoid B from the results of controlled field trials.
    Hejfec LB
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(2):173-82. PubMed ID: 4996607
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of typhoid-paratyphoid vaccines obtained from bacterial extracts absorbed on mineral support. IV. Comparative immunobiological study of typhoid paratyphoid antigenic extracts absorbed on mineral support].
    TOMA S; BARBER C; SORU E; GRITAENCO V; BOGOKOWSKY B
    C R Seances Soc Biol Fil; 1957; 151(1):50-1. PubMed ID: 13447310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.